ZA200510324B - Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof - Google Patents
Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereofInfo
- Publication number
- ZA200510324B ZA200510324B ZA200510324A ZA200510324A ZA200510324B ZA 200510324 B ZA200510324 B ZA 200510324B ZA 200510324 A ZA200510324 A ZA 200510324A ZA 200510324 A ZA200510324 A ZA 200510324A ZA 200510324 B ZA200510324 B ZA 200510324B
- Authority
- ZA
- South Africa
- Prior art keywords
- perindopril
- synthesis
- pharmaceutically acceptable
- acceptable salts
- novel method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03291600A EP1362864B1 (fr) | 2003-06-30 | 2003-06-30 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200510324B true ZA200510324B (en) | 2007-03-28 |
Family
ID=29266055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200510324A ZA200510324B (en) | 2003-06-30 | 2004-06-28 | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7220776B2 (xx) |
| EP (1) | EP1362864B1 (xx) |
| JP (1) | JP4347342B2 (xx) |
| CN (1) | CN100383159C (xx) |
| AR (1) | AR044943A1 (xx) |
| AT (1) | ATE360638T1 (xx) |
| AU (1) | AU2004255899B2 (xx) |
| CY (1) | CY1106471T1 (xx) |
| DE (1) | DE60313391T2 (xx) |
| DK (1) | DK1362864T3 (xx) |
| EA (1) | EA009458B1 (xx) |
| ES (1) | ES2286393T3 (xx) |
| HK (1) | HK1089187A1 (xx) |
| MY (1) | MY136938A (xx) |
| NZ (1) | NZ544004A (xx) |
| PL (1) | PL211491B1 (xx) |
| PT (1) | PT1362864E (xx) |
| SI (1) | SI1362864T1 (xx) |
| WO (1) | WO2005005461A2 (xx) |
| ZA (1) | ZA200510324B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ548212A (en) | 2003-12-29 | 2010-07-30 | Sepracor Inc | Pyrrole and pyrazole DAAO inhibitors |
| ES2314583T4 (es) | 2005-01-06 | 2009-05-18 | Ipca Laboratories Limited | Proceso para sintesis de los derivados del acido (2s,3as,7as)-1-(s)-alanil-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindropil. |
| EP1904066B1 (en) | 2005-07-06 | 2018-05-23 | Sunovion Pharmaceuticals Inc. | COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS |
| JP5432526B2 (ja) | 2006-01-06 | 2014-03-05 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害剤としてのシクロアルキルアミン |
| KR101381768B1 (ko) | 2006-01-06 | 2014-04-07 | 선오비온 파마슈티컬스 인코포레이티드 | 테트랄론-기재 모노아민 재흡수 저해제 |
| AU2007233041B2 (en) | 2006-03-31 | 2013-05-02 | Sepracor Inc. | Preparation of chiral amides and amines |
| US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| JP2008019214A (ja) * | 2006-07-13 | 2008-01-31 | Shiono Chemical Co Ltd | ペリンドプリルまたはその誘導体の製造方法 |
| US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| NZ580429A (en) | 2007-05-31 | 2012-04-27 | Sepracor Inc | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
| CN111116709B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种培哚普利制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
| DE60300581T2 (de) * | 2003-03-12 | 2006-01-19 | Les Laboratoires Servier | Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmba- ren Salzen |
| ATE315043T1 (de) * | 2003-06-30 | 2006-02-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen |
-
2003
- 2003-06-30 ES ES03291600T patent/ES2286393T3/es not_active Expired - Lifetime
- 2003-06-30 AT AT03291600T patent/ATE360638T1/de active
- 2003-06-30 EP EP03291600A patent/EP1362864B1/fr not_active Expired - Lifetime
- 2003-06-30 PT PT03291600T patent/PT1362864E/pt unknown
- 2003-06-30 DK DK03291600T patent/DK1362864T3/da active
- 2003-06-30 SI SI200330844T patent/SI1362864T1/sl unknown
- 2003-06-30 DE DE60313391T patent/DE60313391T2/de not_active Expired - Lifetime
-
2004
- 2004-06-28 WO PCT/FR2004/001638 patent/WO2005005461A2/fr active Application Filing
- 2004-06-28 MY MYPI20042539A patent/MY136938A/en unknown
- 2004-06-28 EA EA200501900A patent/EA009458B1/ru not_active IP Right Cessation
- 2004-06-28 PL PL379630A patent/PL211491B1/pl unknown
- 2004-06-28 ZA ZA200510324A patent/ZA200510324B/xx unknown
- 2004-06-28 US US10/562,950 patent/US7220776B2/en not_active Expired - Fee Related
- 2004-06-28 JP JP2006515296A patent/JP4347342B2/ja not_active Expired - Fee Related
- 2004-06-28 AU AU2004255899A patent/AU2004255899B2/en not_active Ceased
- 2004-06-28 CN CNB2004800163249A patent/CN100383159C/zh not_active Expired - Fee Related
- 2004-06-28 NZ NZ544004A patent/NZ544004A/xx not_active IP Right Cessation
- 2004-06-29 AR ARP040102276A patent/AR044943A1/es not_active Application Discontinuation
-
2006
- 2006-08-30 HK HK06109648A patent/HK1089187A1/xx not_active IP Right Cessation
-
2007
- 2007-05-16 CY CY20071100663T patent/CY1106471T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106471T1 (el) | 2012-01-25 |
| ES2286393T3 (es) | 2007-12-01 |
| CN100383159C (zh) | 2008-04-23 |
| DK1362864T3 (da) | 2007-09-17 |
| DE60313391T2 (de) | 2008-01-17 |
| EP1362864A1 (fr) | 2003-11-19 |
| ATE360638T1 (de) | 2007-05-15 |
| AR044943A1 (es) | 2005-10-12 |
| JP4347342B2 (ja) | 2009-10-21 |
| AU2004255899A1 (en) | 2005-01-20 |
| JP2008500263A (ja) | 2008-01-10 |
| PT1362864E (pt) | 2007-07-23 |
| MY136938A (en) | 2008-11-28 |
| WO2005005461A3 (fr) | 2005-03-31 |
| EA009458B1 (ru) | 2007-12-28 |
| SI1362864T1 (sl) | 2007-08-31 |
| EP1362864B1 (fr) | 2007-04-25 |
| CN1805972A (zh) | 2006-07-19 |
| WO2005005461A2 (fr) | 2005-01-20 |
| AU2004255899B2 (en) | 2008-03-13 |
| DE60313391D1 (de) | 2007-06-06 |
| US20060148884A1 (en) | 2006-07-06 |
| HK1089187A1 (en) | 2006-11-24 |
| EA200501900A1 (ru) | 2006-06-30 |
| PL379630A1 (pl) | 2006-10-30 |
| NZ544004A (en) | 2009-03-31 |
| PL211491B1 (pl) | 2012-05-31 |
| US7220776B2 (en) | 2007-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1089187A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| AP2002002630A0 (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| EG26629A (en) | A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts | |
| AU2001248470A1 (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| HK1096409A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| HK1089188A1 (en) | Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof | |
| EG24152A (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril | |
| HK1096408A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| HK1095839A1 (en) | Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
| PT1753720E (pt) | Processo para a preparação de perindopril e sais do mesmo | |
| SI1371659T1 (sl) | Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli | |
| HK1086281A1 (en) | Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof | |
| HK1096406A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| HK1096407A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| SI1422236T1 (sl) | Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli | |
| SI1268424T1 (sl) | Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli |